Cuba in Qatar

HH the Emir sends Congratulations to President of Cuba

H H el Emir de Catar


Doha, January 01, 2017.-HH the Emir of the State of Qatar, Sheikh Tamim bin Hamad Al-Thani sent Sunday a message of congratulations to President of the Republic of Cuba Raúl Castro on the anniversary of his Country's Independence Day.

Also on the same date were sent greeting messages to the President of the Republic of Cuba, Raúl Castro Ruz by His Highness, the Deputy Emir of the State of Qatar, Sheikh Abdullah bin Hamad al-Thani and the Prime Minister and Interior Minister, His Excellency Sheikh Abdullah bin Nasser bin Khalifa Al-Thani.


January First, 1959: Victory of the People

Primero de Enero

Cuban Revolution of the humble and for the humble

“Celebrate this January, celebrate together, raise our glasses and toast for Cuba and our Revolution, for which, as expressed the undefeated Fidel: "It is a Revolution for social justice."

By Ana Hernández

Raúl: We are not going back, nor will we go back, to capitalism, this is totally ruled out

Raul Castro

Thus emphasized Army General Raúl Castro Ruz, President of the Councils of State and Ministers, closing the eight period of ordinary sessions of the National Assembly of People's Power.

The historic leader of the Cuban Revolution has bequeathed to us his example, his optimism, and confidence in victory. The best monument to his ideas and work is to make a reality of the postulates he outlined in his concept of Revolution, which he announced May 1, 2000, and to which millions of Cubans expressed their commitment.

Happy New Year 2017



The Cuban Embassy in the State of Qatar wishes to all its readers a "Happy New Year 2017", with good health, peace and progress for all.


Cuban lung cancer vaccine in last stage of clinical trials


Havana, Cuba, Dec 20 (acn) The CIMAvax-EGF vaccine against lung cancer, created by Cuban scientists at the Center for Molecular Immunology, goes through its last phase of clinical trial in the province of Cienfuegos.

According to Granma newspaper, this is the first therapeutic treatment registered against lung cancer that generates antibodies against the epidermal growth factor (EGF) of the patient.